Source: Health Canada shortage reports · Updated Aug 7, 2026
A shortage of Cytarabine is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A chemotherapy medication used to treat leukemia and lymphoma.
Products affected
0 / 3
Reports on file
18
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
CYTARABINE INJECTION
100MG · SOLUTION · PFIZER CANADA ULC
DIN 02126656 · Disruption of the manufacture of the drug.
Anticipated
CYTARABINE INJECTION
100MG · SOLUTION · PFIZER CANADA ULC
DIN 02126656 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
100MG · SOLUTION · PHARMASCIENCE INC
DIN 02406772 · ended Aug 15, 2025 · Disruption of the manufacture of the drug.
Resolved
CYTARABINE INJECTION
100MG · SOLUTION · PFIZER CANADA ULC
DIN 02126656 · ended Jun 5, 2024 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
100MG · SOLUTION · PHARMASCIENCE INC
DIN 02406772 · ended Feb 15, 2022 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
20MG · SOLUTION · PHARMASCIENCE INC
DIN 02406764 · ended Dec 13, 2021 · Disruption of the manufacture of the drug.
Resolved
CYTARABINE INJECTION
100MG · SOLUTION · PFIZER CANADA ULC
DIN 02126656 · ended Dec 8, 2021 · Demand increase for the drug.
Resolved
PMS-CYTARABINE
100MG · SOLUTION · PHARMASCIENCE INC
DIN 02406772 · ended Nov 19, 2021 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
100MG · SOLUTION · PHARMASCIENCE INC
DIN 02406772 · ended Jun 9, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
20MG · SOLUTION · PHARMASCIENCE INC
DIN 02406764 · ended Jun 9, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
100MG · SOLUTION · PHARMASCIENCE INC
DIN 02406772 · ended Jun 5, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-CYTARABINE
100MG · SOLUTION · PHARMASCIENCE INC
DIN 02406772 · ended Nov 1, 2019 · Demand increase for the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Cytarabine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Cytarabine is classified under “ANTIMETABOLITES” (ATC L01BC).
Recent changes
Aug 7, 2026
New report filed
Aug 7, 2026
New report filed
Common questions
What is Cytarabine used for?
A chemotherapy medication used to treat leukemia and lymphoma.
When will Cytarabine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cytarabine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.